Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Multiple Myeloma Management in 2020
EP. 1: Treatment for High-Risk Asymptomatic Myeloma
January 29th 2020
EP. 2: Emerging Regimens for Smoldering Myeloma
January 29th 2020
EP. 3: Induction Therapy for Myeloma
January 29th 2020
EP. 4: Initial Therapy for High-Risk Myeloma
January 29th 2020
EP. 5: Transplant-Eligible Multiple Myeloma
January 29th 2020
EP. 6: MRD as a Composite End Point in Myeloma
January 29th 2020
EP. 7: Outcomes With Transplant in Myeloma
January 29th 2020
EP. 8: CD38-Targeted Monoclonal Antibodies in Myeloma
January 29th 2020
EP. 9: Choosing Front-Line Therapy for Myeloma
January 29th 2020
EP. 10: Nuances of Using Frontline Daratumumab for Myeloma
January 29th 2020
EP. 11: Considering Daratumumab-Based Quadruplets for Myeloma
January 29th 2020
EP. 12: Maintenance Therapy for Multiple Myeloma
January 29th 2020
EP. 13: Outcomes for Relapsed/Refractory Myeloma
January 29th 2020
EP. 14: Treatment Options for Lenalidomide-Refractory Myeloma
January 29th 2020
EP. 15: Coming Soon: Isatuximab + Pom/Dex for Relapsed Myeloma
January 29th 2020
EP. 16: BCMA-Targeted Approaches for Relapsed Myeloma
January 29th 2020
EP. 17: Real-World Use of BCMA-Targeted Therapy in Myeloma
January 29th 2020